Drug Type Small molecule drug |
Synonyms Athyromazole, Carbethoxymethimazole, Carbimazole (INN) + [6] |
Target |
Mechanism TPO inhibitors(Thyroid peroxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date AU (23 May 2012), |
Regulation- |
Molecular FormulaC7H10N2O2S |
InChIKeyCFOYWRHIYXMDOT-UHFFFAOYSA-N |
CAS Registry22232-54-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07616 | Carbimazole |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Thyrotoxicosis | AU | 23 May 2012 | |
Hyperthyroidism | AU | 23 May 2012 |
Not Applicable | 15 | Carbimazole 5 mg 2x3 daily for 2 weeks | zxpubzgtrh(gijsahgnew) = pjyhdqrvgn iuwywcfavp (gnrqplzaag, 5.9) | Positive | 05 Nov 2014 | ||
Carbimazole 5 mg 3x3 daily for 1-2 weeks | zxpubzgtrh(gijsahgnew) = orragfvykh iuwywcfavp (gnrqplzaag, 14.6) |